Immediate Impact of Induction Treatment on Postvaccination SARS-CoV-2 Serology in Kidney Transplant Recipients
- PMID: 34149002
- PMCID: PMC8487697
- DOI: 10.1097/TP.0000000000003862
Immediate Impact of Induction Treatment on Postvaccination SARS-CoV-2 Serology in Kidney Transplant Recipients
Conflict of interest statement
The authors declare no funding or conflicts of interest.
Figures
Comment on
-
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis.Clin J Am Soc Nephrol. 2021 Jul;16(7):1037-1042. doi: 10.2215/CJN.03500321. Epub 2021 Apr 6. Clin J Am Soc Nephrol. 2021. PMID: 33824157 Free PMC article.
-
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489. JAMA. 2021. PMID: 33950155 Free PMC article.
References
-
- Yi SG, Knight RJ, Graviss EA, et al. . Kidney transplant recipients rarely show an early antibody response following the first COVID-19 vaccine administration. Transplantation. 2021;105:e72–e73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous